Variant report
Variant | esv3436278 |
---|---|
Chromosome Location | chr6:38841674-38842722 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188187267 | chr6:38841744-38841745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147664774 | chr6:38841814-38841815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs386358936 | chr6:38841816-38841817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201478372 | chr6:38841817-38841818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375242583 | chr6:38841839-38841840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111786820 | chr6:38841843-38841844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377254876 | chr6:38841844-38841845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs66810592 | chr6:38841845-38841846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541834450 | chr6:38841846-38841847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76378769 | chr6:38841848-38841849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71746049 | chr6:38841853-38841854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540223822 | chr6:38841861-38841862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200351028 | chr6:38841877-38841878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs367852853 | chr6:38841897-38841898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371660123 | chr6:38841918-38841919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200418777 | chr6:38841957-38841958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201503679 | chr6:38841977-38841978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202063752 | chr6:38841980-38841981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199774533 | chr6:38842024-38842025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148480769 | chr6:38842030-38842031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142733552 | chr6:38842038-38842039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs180911360 | chr6:38842084-38842085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151012483 | chr6:38842089-38842090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573655926 | chr6:38842108-38842109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542390440 | chr6:38842123-38842124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562614782 | chr6:38842183-38842184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531787359 | chr6:38842188-38842189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545201933 | chr6:38842245-38842246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71571354 | chr6:38842276-38842277 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs528019959 | chr6:38842292-38842293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547385295 | chr6:38842331-38842332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560976166 | chr6:38842332-38842333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187017007 | chr6:38842480-38842481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78092995 | chr6:38842488-38842489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570138335 | chr6:38842529-38842530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112979289 | chr6:38842579-38842580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577948656 | chr6:38842603-38842604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113416730 | chr6:38842605-38842606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35883575 | chr6:38842699-38842700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Lung cancer | 19153074 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 21693616 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Breast cancer | 16397240 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Glioblastoma multiforme | 21510904 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:38840200-38843400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
2 | chr6:38840200-38845400 | Enhancers | Fetal Thymus | thymus |
3 | chr6:38841000-38843800 | Weak transcription | Primary T cells fromperipheralblood | blood |
4 | chr6:38841000-38844000 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr6:38841200-38842200 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
6 | chr6:38841200-38842200 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
7 | chr6:38841200-38842200 | Weak transcription | Thymus | Thymus |
8 | chr6:38841200-38842800 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
9 | chr6:38841200-38843400 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
10 | chr6:38841200-38843800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr6:38841200-38843800 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
12 | chr6:38841400-38842200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
13 | chr6:38841400-38843800 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
14 | chr6:38842200-38842400 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
15 | chr6:38842200-38842400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr6:38842200-38844000 | Enhancers | Thymus | Thymus |
17 | chr6:38842200-38845400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
18 | chr6:38842200-38845800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
19 | chr6:38842400-38842800 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
20 | chr6:38842400-38843600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |